Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Exp Parasitol ; 199: 47-51, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30825499

ABSTRACT

The aim of this study was to evaluate in vitro the efficacy of cordycepin and pentostatin (alone or combined) against Trypanosoma cruzi, as well as the therapeutic efficiency of protocols of cordycepin and pentostatin combinations in mice experimentally infected with T. cruzi. In vitro, the cordycepin (3'-deoxyadenosine) and pentostatin (deoxycoformycin) exerted potent trypanocidal effect against T. cruzi (Colombian strain), similarly to benznidazole, which is the reference drug. For epimastigotes, the lethal dose of cordycepin capable of killing 50% (LD50) and 20% (LD20) of the parasites was 0.072 and 0.031 mg/mL, respectively and for trypomastigotes was 0.047 and 0.015 mg/mL, respectively. The combined use of cordycepin and pentostatin resulted in a LD50 and LD20 for epimastigotes of 0.068 and 0.027 mg/mL, respectively, as well as 0.056 and 0.018 mg/mL for trypomastigotes, respectively. In vivo, the combined use of cordycepin and pentostatin did not show the expected curative effect, however it was able to control the parasitema in the peak period. In summary, the combination of cordycepin and pentostatin showed no curative effect in mice infected by T. cruzi, despite the in vitro reduction of epimastigotes and trypomastigotes.


Subject(s)
Antiprotozoal Agents/pharmacology , Chagas Disease/drug therapy , Deoxyadenosines/pharmacology , Pentostatin/pharmacology , Trypanosoma cruzi/drug effects , Analysis of Variance , Animals , Antiprotozoal Agents/adverse effects , Antiprotozoal Agents/therapeutic use , Chagas Disease/parasitology , Deoxyadenosines/therapeutic use , Dose-Response Relationship, Drug , Drug Therapy, Combination , Female , Heart/drug effects , Lethal Dose 50 , Mice , Myocardium/pathology , Neglected Diseases/drug therapy , Neglected Diseases/parasitology , Nifurtimox/adverse effects , Nifurtimox/therapeutic use , Nitroimidazoles/adverse effects , Nitroimidazoles/therapeutic use , Nonlinear Dynamics , Parasitemia/prevention & control , Pentostatin/therapeutic use , Random Allocation , Regression Analysis
2.
Mol Cell Biochem ; 447(1-2): 203-208, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29404886

ABSTRACT

The aim of this study was to evaluate whether Trypanosma cruzi infections cause alterations in the levels of seric purines, which could contribute to host immunomodulation. Twelve mice were divided into two groups identified as control (uninfected) and infected (T. cruzi) groups. The influence of the disease on seric purine levels was verified on day 20 post-infection (PI) by HPLC. Infected mice had circulating trypomastigotes during the experiment, as well as amastigote forms in the heart associated with inflammatory infiltrates. Increases on adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine (ADO), inosine (INO), and uric acid (URIC) levels were observed in the infected animals, while the adenosine monophosphate (AMP) and xanthine (XAN) levels were reduced compared with mice of the control group, indicating a possible impairment on the purinergic system, and consequently, on the immune system during the clinical course of the disease. In summary, the T. cruzi infection alters the seric purine levels, and consequently, modulates the immune system.


Subject(s)
Chagas Cardiomyopathy/immunology , Immunomodulation , Purine Nucleosides/immunology , Purine Nucleotides/immunology , Trypanosoma cruzi/immunology , Animals , Chagas Cardiomyopathy/parasitology , Chagas Cardiomyopathy/pathology , Disease Models, Animal , Female , Mice
3.
Mol Cell Biochem ; 438(1-2): 59-65, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28766165

ABSTRACT

Chagas disease is an acute or chronic illness that causes severe inflammatory response, and consequently, it may activate the inflammatory cholinergic pathway, which is regulated by cholinesterases, including the acetylcholinesterase. This enzyme is responsible for the regulation of acetylcholine levels, an anti-inflammatory molecule linked to the inflammatory response during parasitic diseases. Thus, the aim of this study was to investigate whether Trypanosoma cruzi infection can alter the activity of acetylcholinesterase and acetylcholine levels in mice, and whether these alterations are linked to the inflammatory cholinergic signaling pathway. Twenty-four mice were divided into two groups: uninfected (control group, n = 12) and infected by T. cruzi, Y strain (n = 12). The animals developed acute disease with a peak of parasitemia on day 7 post-infection (PI). Blood, lymphocytes, and brain were analyzed on days 6 and 12 post-infection. In the brain, acetylcholine and nitric oxide levels, myeloperoxidase activity, and histopathology were analyzed. In total blood and brain, acetylcholinesterase activity decreased at both times. On the other hand, acetylcholinesterase activity in lymphocytes increased on day 6 PI compared with the control group. Infection by T. cruzi increased acetylcholine and nitric oxide levels and histopathological damage in the brain of mice associated to increased myeloperoxidase activity. Therefore, an intense inflammatory response in mice with acute Chagas disease in the central nervous system caused an anti-inflammatory response by the activation of the cholinergic inflammatory pathway.


Subject(s)
Acetylcholine/blood , Acetylcholinesterase/blood , Brain/metabolism , Chagas Cardiomyopathy/blood , Lymphocytes/metabolism , Trypanosoma cruzi , Animals , Brain/pathology , Chagas Cardiomyopathy/pathology , Lymphocytes/pathology , Mice , Nitric Oxide/blood , Peroxidase/blood
4.
Microb Pathog ; 113: 51-56, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29051060

ABSTRACT

The aim of this study was to evaluate the efficacy of 3'-deoxyadenosine and deoxycoformycin combination in the treatment of mice infected by T. cruzi, as well as to verify the influence of the treatment on purinergic enzymes. Heart and serum samples were collected from 60 mice (30 infected and 30 uninfected) at day 12 post-infection. To verify treatment efficacy, parasitemia was monitored, and the treatment with 3'-deoxy adenosine and deoxycoformycin combination was able to reduce it, but had no curative effect on mice. Seric activities of NTPDase (ATP and ADP substrate) and ADA were increased significantly in untreated mice infected by T. cruzi compared to the negative control, as well as mice treated with 3'-deoxyadenosine and deoxycoformycin (alone or combined) modulated the activity of NTPDase (ATP and ADP substrate), preventing them from increasing in infected animals (activity similar to healthy animals). Treatment with deoxycoformycin alone and associated with 3'-deoxyadenosine modulated the activity of ADA preventing them from increasing in infected animals. However, seric activities of ADA in mice treated with 3'-deoxyadenosine (cordycepin) alone does not modify the ADA activity compared with infected and non-treated mice. However, the 5'-nucleotidase activity decreased significantly in infected untreated animals and the same occurred in infected and treated animals with deoxycoformycin and 3'-deoxyadenosine. However, treatment with deoxycoformycin associated with 3'-deoxyadenosine preventing them from decreasing the 5'-nucleotidase activity. Therefore, we conclude that the treatments did not have curative success for mice infected by T. cruzi. However, the treatments were able to modulate the purinergic enzymes during the infection by T. cruzi, which may contribute to reduce the inflammatory damage in heart.


Subject(s)
Antiprotozoal Agents/therapeutic use , Chagas Disease/drug therapy , Deoxyadenosines/therapeutic use , Parasitemia/drug therapy , Pentostatin/therapeutic use , Trypanosoma cruzi/drug effects , Adenosine Deaminase/metabolism , Animals , Chagas Disease/parasitology , Drug Therapy, Combination , Female , Mice , Parasitemia/parasitology , Pyrophosphatases/metabolism
5.
J Immunol Methods ; 449: 56-61, 2017 10.
Article in English | MEDLINE | ID: mdl-28697990

ABSTRACT

Trypanosoma cruzi is a flagellated protozoan belonging to the Trypanosomatidae family, the etiologic agent of Chagas disease. Currently, there is neither a licensed vaccine nor effective treatment, characterizing an unmet clinical need. The IgY refers to the egg yolk immunoglobulin (Y=yolk) and its production and use are subjects of many studies due to the diversity of its diagnostic and therapeutic applications. Several researchers have shown that the use of specific IgY may prevent and/or control infectious and parasitic diseases. Based on these evidences, the aim of this study was to immunize chickens with trypomastigotes of T. cruzi in order to produce highly effective and pure antibodies (IgY), as well as extract, characterize, quantify, and verify cytotoxic effects of IgY anti-T. cruzi. After the induction of IgY production by chickens, the eggs were collected and the IgY was extracted by method of precipitation of polyethylene glycol 6000. The IgY anti-T. cruzi characterization was performed using polyacrylamide gel electrophoresis (SDS-PAGE), western-blot and enzyme-linked immunosorbent assay (ELISA). Moreover, the cytotoxic or proliferative effects of IgY anti-T. cruzi was verified by MTT assay. The concentration of IgY in yolk was 8.41±1.47mg/mL. The characterization of IgY reveled bands of stained peptides with molecular weight between 75 and 50kDa and 37 and 25kDa. In the ELISA test was observed that there was antigen-antibody reaction throughout the sample period. The concentrations of 1, 5 and 10mg/mL of IgY anti-T. cruzi presented no cytotoxic of proliferative effects in mononuclear and VERO cells in vitro. The results indicated that T. cruzi is able to generate a high production of specific immunoglobulins in chickens, it did not cause damage to the cell membrane and no proliferative effect.


Subject(s)
Antibodies, Protozoan/immunology , Antibodies, Protozoan/isolation & purification , Chickens/immunology , Immunoglobulins/immunology , Immunoglobulins/isolation & purification , Trypanosoma cruzi/immunology , Animals , Antibodies, Protozoan/biosynthesis , Blotting, Western , Chlorocebus aethiops , Cytotoxicity Tests, Immunologic , Egg Yolk/chemistry , Egg Yolk/immunology , Electrophoresis, Polyacrylamide Gel , Enzyme-Linked Immunosorbent Assay , Immunization , Immunoglobulins/biosynthesis , Vero Cells
6.
Mol Cell Biochem ; 432(1-2): 1-6, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28285362

ABSTRACT

Coagulation disorders have been described in Chagas disease with thrombocytopenia as an important event. Several mechanisms may be related to this pathogenesis, such as enzymes of the purinergic system, purine, and receptors involved in the regulation and modulation of physiological events related to hemostasis. Therefore, the aim of this study was to evaluate the activities of E-NTPDase, E-5'nucleotidase, and ecto-adenosine deaminase (E-ADA) in platelets of mice experimentally infected by Trypanosoma cruzi. Twelve female mice were used, divided into two groups (n = 6): uninfected and infected. Mice of infected group were intraperitoneally inoculated with 104 trypomastigotes of T. cruzi (strain Y). On day 12 post-infection (PI), blood samples were collected for quantitation and separation of platelets. A significant reduction in the number of platelets of infected mice (P < 0.05) was observed. The activities of E-NTPDase (ATP and ADP substrates), E-5'nucleotidase, and E-ADA in platelets increased significantly (P < 0.05) in mice infected by T. cruzi compared with uninfected animals. A negative correlation (P < 0.01)was observed between the number of platelets and ATP hydrolysis (r = -0.64), and ADP hydrolysis (r = -0.69) by E-NTPDase. Therefore, there is a response from the purinergic system activating ecto-enzymes in platelets of mice T. cruzi infected, as a compensatory effect of thrombocytopenia.


Subject(s)
Adenosine Deaminase/metabolism , Blood Platelets/metabolism , Chagas Disease/enzymology , Protozoan Proteins/metabolism , Thrombocytopenia/enzymology , Trypanosoma cruzi/enzymology , Adenosine Triphosphate/metabolism , Animals , Blood Platelets/pathology , Female , Mice , Thrombocytopenia/parasitology , Thrombocytopenia/pathology
7.
Exp Parasitol ; 175: 44-50, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28167210

ABSTRACT

The aim of this study was to evaluate the activity of purinergic enzymes in lymphocytes and cardiac tissue of mice experimentally infected by Trypanosoma cruzi. Twelve female mice were used, divided into two groups (n = 6): uninfected and infected. On day 12 post-infection (PI), the animals were anesthetized and after euthanized, and samples were collected for analyses. Infected mice showed reduction in erythrocyte counts, hematocrit and hemoglobin concentration, as well as reduced number of total leukocytes in consequence of neutrophilia (P < 0.01). The number of monocytes increased in infected mice (P < 0.001), however the number of lymphocytes and eosinophils did not differ between groups (P > 0.05). The E-NTPDase (ATP and ADP substrate) and E-ADA activities in lymphocytes increased significantly in mice infected by T. cruzi (P < 0.01). In the heart, multiple pseudocysts containing amastigotes within cardiomyocytes were observed, as well as focally extensive severe necrosis associated with diffuse moderate to severe inflammatory infiltrate of lymphocytes. Although, the NTPDase activity (ATP and ADP substrate) in the cardiac homogenate did not differ between groups, a reduction on 5'-nucleotidase activity (P < 0.001) and an increase in the ADA activity in infected animals (P < 0.05) were observed. Thus, animals infected by T. cruzi experienced the disease, i.e., showed anemia, leucopenia, and heart lesions. Associated with this, purinergic enzymes showed altered activities, which might be related to the modulation of the inflammatory response.


Subject(s)
Chagas Disease/enzymology , Lymphocytes/enzymology , Myocytes, Cardiac/enzymology , Purines/metabolism , 5'-Nucleotidase/metabolism , Adenosine/metabolism , Adenosine Diphosphate/metabolism , Adenosine Monophosphate/metabolism , Adenosine Triphosphate/metabolism , Animals , Antigens, CD/metabolism , Apyrase/metabolism , Chagas Disease/pathology , Disease Models, Animal , Female , Heart/parasitology , Hematologic Tests , Hydrolysis , Mice , Myocardium/pathology , Parasitemia/parasitology , Trypanosoma cruzi/physiology
8.
Microb Pathog ; 103: 162-166, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28027943

ABSTRACT

The aim of this study was to analyses nitric oxide, antioxidant status, and oxidative profile in the liver of laying hens naturally infected by Salmonella enterica subsp enterica serovar Gallinarum (S. Gallinarum). The nitrite/nitrate (NOx), reactive oxygen species (ROS), thiobarbituric acid-reactive substances (TBARS), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST) activities were measured in liver samples, as well the biomarkers of hepatic function (alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (GGT), total protein and albumin levels measured in serum. NOx levels and CAT activity were reduced in hepatic tissue of infected hens. On the other hand, TBARS and ROS levels, GR, GPx and GST activities were higher in infected animals. On biomarkers of tissue damage, ALT, AST, GGT and total protein levels were higher in serum of infected hens, and showed decreased albumin levels. In summary, ROS and TBARS production lead to damage on the membrane lipids that alter activities of antioxidant enzymes CAT, GR, GPx and GSH, an adaptive response against S. Gallinarum infection, contributing to the pathophysiology and clinical signs of the disease.


Subject(s)
Chickens , Liver/microbiology , Liver/pathology , Oxidative Stress , Poultry Diseases/metabolism , Salmonella Infections, Animal/metabolism , Salmonella enterica , Animals , Catalase/metabolism , Glutathione/metabolism , Glutathione Transferase/metabolism , Liver/metabolism , Nitric Oxide , Oxidation-Reduction , Poultry Diseases/microbiology , Poultry Diseases/pathology , Reactive Oxygen Species , Salmonella Infections, Animal/microbiology , Salmonella Infections, Animal/pathology
9.
Microb Pathog ; 98: 93-7, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27377431

ABSTRACT

Salmonella is a facultative intracellular pathogen that may cause foodborne gastroenteritis in humans and animals consisting of over 2000 serovars. The serovar Salmonella Gallinarum is an important worldwide pathogen of poultry. However, little is known on the mechanisms of pathogenesis of Salmonella in chickens. The aim of this study was to evaluate cholinesterase and myeloperoxidase activities in hepatic tissue of laying hens naturally infected by S. Gallinarum. Twenty positive liver samples for S. Gallinarum were collected, in addition to seven liver samples from healthy uninfected laying hens (control group). The right liver lobe was homogenized for analysis of acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and myeloperoxidase (MPO), and the left lobe was divided into two fragments, one for histopathology and the other for Salmonella isolation. The results showed changes in AChE and BchE activity in the liver of infected laying hens compared to the control group (P < 0.05), i.e. reduced AChE and increased BChE activities in liver samples. Infected animals showed increased MPO activity compared to healthy animals (P < 0.05). Furthermore, the histopathological findings showed fibrinoid necrosis associated to the infiltration of lymphocytes, plasma cells, macrophages,heterophils in the liver of infected hens. These findings suggest that the inflammatory process was attenuated providing a pro-inflammatory action of both enzyme analyzed in order to reduce the free ACh, a molecule which has an anti-inflammatory action. Therefore, our results lead to the hypothesis that cholinesterase plays an important role on the modulation of immune response against S. Gallinarum with an inflammatory effect, contributing to the response against this bacterium. This study should contribute to a better understanding on the pathogenic mechanisms involved in laying hens infected by S. Gallinarum.


Subject(s)
Acetylcholinesterase/analysis , Butyrylcholinesterase/analysis , Liver/pathology , Poultry Diseases/pathology , Salmonella Infections, Animal/pathology , Salmonella enterica/isolation & purification , Animals , Histocytochemistry , Liver/microbiology , Microscopy , Peroxidase/analysis , Poultry Diseases/microbiology , Salmonella Infections, Animal/microbiology
10.
Microb Pathog ; 93: 180-4, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26911648

ABSTRACT

Salmonella Gallinarum is the etiologic agent of fowl typhoid that affects chickens and turkeys causing egg production drops, infertility, lower hatchability, high mortality, and as a consequence severe economic losses to the poultry industry. The alterations in NTPDase and adenosine deaminase (ADA) activities have been demonstrated in several inflammatory conditions; however, there are no data in the literature associated with this infection. Thus, the aim of this study was to evaluate the activities of NTPDase, 5'nucleotidase, and ADA in serum and hepatic tissue of laying hens naturally infected by Salmonella Gallinarum. Liver and serum samples were collected of 27 laying hens (20 S. Gallinarum infected and 7 uninfected). NTPDase and 5'-nucleotidase activities in serum were increased (P < 0.001) in infected animals to hydrolysis of substrate ATP, ADP and AMP. In addition, it was observed decreased (P < 0.001) in ADA activity in serum of laying hens naturally infected by S. Gallinarum; as well as increased (P < 0.001) ADA activity in liver tissue of infected laying hens. Histopathological analyses revealed that S. Gallinarum caused fibrinoid necrosis in liver and spleen associated with infiltrates of heterophils, macrophages, lymphocytes, and plasma cells. Considering that NTPDase and ADA are involved in the cell-mediated immunity, this study suggests that activities of these enzymes could be important biomarkers to determine the severity of inflammatory and immune responses in salmonellosis, contributing to clarify the pathogenesis of the disease.


Subject(s)
Adenosine Deaminase/immunology , Nucleotidases/immunology , Poultry Diseases/enzymology , Salmonella Infections, Animal/enzymology , Salmonella enterica/physiology , Adenosine Deaminase/genetics , Animals , Chickens/microbiology , Female , Immunity, Cellular , Liver/microbiology , Liver/pathology , Nucleotidases/genetics , Poultry Diseases/immunology , Poultry Diseases/microbiology , Poultry Diseases/pathology , Salmonella Infections, Animal/immunology , Salmonella Infections, Animal/microbiology , Salmonella Infections, Animal/pathology , Spleen/microbiology , Spleen/pathology
11.
Article in English | MEDLINE | ID: mdl-26616656

ABSTRACT

The aim of this study was to evaluate the role of butyrylcholinesterase (BChE) as a marker of inflammation and liver injury in the acute and subclinical phases of canine ehrlichiosis. Forty-two serum samples of dogs naturally infected with Ehrlichia canis were used, of which 24 were from animals with the acute phase of the disease and 18 with subclinical disease. In addition, sera from 17 healthy dogs were used as negative controls. The hematocrit, BChE activity, hepatic injury (alanine aminotransferase (ALT) and aspartate aminotransferase (AST)), nitric oxide, and cytokines levels were evaluated. The BChE activity was significantly elevated (P<0.05) in dogs with the acute phase of the disease when compared to healthy animals. However, there was a reduction on BChE activity on dogs with subclinical disease compared to the other two groups. AST and ALT levels were significantly higher (P<0.05) in the acute phase, as well as the inflammatory mediators (NOx, TNF-α, INF-γ, IL-4, IL-6) when compared to the control group. On the other hand, IL-10 levels were lower in the acute phase. Based on these results, we are able to conclude that the acute infection caused by E. canis in dogs leads to an increase on seric BChE activity and some inflammatory mediators. Therefore, this enzyme might be used as a marker of acute inflammatory response in dogs naturally infected by this bacterium.


Subject(s)
Biomarkers/blood , Butyrylcholinesterase/blood , Dog Diseases/enzymology , Dog Diseases/immunology , Ehrlichia canis , Ehrlichiosis/veterinary , Acute Disease , Animals , Asymptomatic Infections , Cytokines/blood , Dogs , Ehrlichiosis/immunology , Ehrlichiosis/microbiology , Ehrlichiosis/physiopathology , Inflammation/enzymology , Liver/physiopathology
12.
Article in English | MEDLINE | ID: mdl-25555997

ABSTRACT

Toxoplasmosis is an important parasitic disease affecting several species of mammals, but little is known about this disease in horses. This study aimed to investigate the levels of several immunological variables and markers of cell damage in the serum of seropositive horses for Toxoplasma gondii. Sera samples of adult horses from the Santa Catarina State, Brazil used on a previous study were divided into groups according to their antibody levels for T. gondii determined by immunofluorescence assay, i.e. 20 samples from seronegative horses (Group A - control), 20 samples from horses with titers of 1:64 (Group B), 20 samples of horses with titers of 1:256 (Group C), and five samples from horses with titers of 1:1024 (Group D). Positive animals (Groups B, C, and D) had higher levels of immunoglobulins (IgM and IgG), pro-inflammatory cytokines (TNF-α, IFN-γ, IL-1, IL-4, and IL-6) and protein C-reactive protein, as well as lower levels of IL-10 (anti-inflammatory cytokine) when compared to seronegative horses (Group A). The nitric oxide levels were also elevated in seropositive horses. Therefore, we have found humoral and cellular immune responses in seropositive horses, and a correlation between high antibody levels and inflammatory mediators. Markers of cell injury by lipid peroxidation (TBARS) and protein oxidation (AOPP) were elevated in animals seropositives for T. gondii when compared to seronegatives. Therefore, seropositive horses to T. gondii can keep active immune responses against the parasite. As a consequence with chronicity of disease, they show cellular lesions that may lead to tissue damage with the appearance of clinical disease.


Subject(s)
Antibodies, Protozoan/blood , Horse Diseases/immunology , Toxoplasma/immunology , Toxoplasmosis, Animal/immunology , Advanced Oxidation Protein Products/analysis , Animals , Antigens, Protozoan/immunology , Brazil , C-Reactive Protein/analysis , Cytokines/metabolism , Horse Diseases/parasitology , Horses , Immunity, Cellular , Lipid Peroxidation
13.
Exp Parasitol ; 149: 39-46, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25499512

ABSTRACT

This study aimed to verify the effect of the treatment with A. satureioides essential oil (free and nanoencapsulated forms) and diminazene aceturate on hematological and biochemical variables in rats infected by Trypanosoma evansi. The 56 rats were divided into seven groups with eight rats each. Groups A, C and D were composed by uninfected animals, and groups B, E, F and G were formed by infected rats with T. evansi. Rats from groups A and B were used as negative and positive control, respectively. Rats from the groups C and E were treated with A. satureioides essential oil, and groups D and F were treated with A. satureioides nanoencapsulated essential oil. Groups C, D, E and F received one dose of oil (1.5 mL kg(-1)) during five consecutive days orally. Group G was treated with diminazene aceturate (D.A.) in therapeutic dose (3.5 mg kg(-1)) in an only dose. The blood samples were collected on day 5 PI for analyses of hematological (erythrocytes and leukocytes count, hemoglobin concentration, hematocrit, mean corpuscular and mean corpuscular hemoglobin concentration) and biochemical (glucose, triglycerides, cholesterol, alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin, urea and creatinine) variables. A. satureioides administered was able to maintain low parasitemia, mainly the nanoencapsulated form, on 5 days post infection. On the infected animals with T. evansi treated with A. satureioides essential oil (free and nanocapsules) the number of total leucocytes, lymphocytes and monocytes present was similar to uninfected rats, and different from infected and not-treated animals (leukocytosis). Treatment with A. satureioides in free form elevated levels of ALT and AST, demonstrating liver damage; however, treatment with nanoencapsulated form did not cause elevation of these enzymes. Finally, treatments inhibited the increase in creatinine levels caused by infection for T. evansi. In summary, the nanoencapsulated form showed better activity on the trypanosome; it did not cause liver toxicity and prevented renal damage.


Subject(s)
Achyrocline/chemistry , Diminazene/analogs & derivatives , Oils, Volatile/therapeutic use , Plant Oils/therapeutic use , Trypanocidal Agents/therapeutic use , Trypanosomiasis/drug therapy , Animals , Biomarkers/blood , Blood Chemical Analysis , Diminazene/administration & dosage , Diminazene/therapeutic use , Dogs , Female , Hematologic Tests , Kidney/physiology , Liver/physiology , Nanocapsules , Oils, Volatile/administration & dosage , Oils, Volatile/chemistry , Parasitemia/parasitology , Plant Oils/administration & dosage , Plant Oils/chemistry , Rats , Rats, Wistar , Trypanocidal Agents/administration & dosage , Trypanosoma/drug effects , Trypanosomiasis/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...